Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NOTA-Aca-BBN(7-14) PET/CT in Primary Gliomas
NCT02520882Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-NOTA-Aca-BBN in glioma, sponsored by Peking Union Medical College Hospital. Primary endpoint: Standardized Uptake Value at 1 year. Status: unknown.
02
Drugs
68Ga-NOTA-Aca-BBN
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02520882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02520882.